Metformin for the Prevention of Episodic Migraine (MPEM)
Status:
Completed
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
The investigators will evaluate the safety and efficacy of metformin for preventive treatment
of migraine in a randomized, double-blind, placebo-controlled, crossover trial.